IGALMI
Generic: dexmedetomidine
Manufacturer: BioXcel Therapeutics · Program:
Apply for AssistanceEligibility Criteria
Insurance Requirement
See program details
Residency
US residency required
Program Information
Processing Time
2–8 weeks
Delivery Method
Varies by program
Application Method
Online
Indicated For
agitation associated with schizophrenia, bipolar I or II disorder
About This Medication
# IGALMI Patient Assistance Program Guide: How to Get IGALMI at Low or No Cost ## About This Program BioXcel Therapeutics, the manufacturer of IGALMI (dexmedetomidine), offers a patient assistance program to help eligible patients access this medication. IGALMI is a prescription sublingual film used for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.[1][2] ## What Is IGALMI? IGALMI is a **sublingual film formulation of dexmedetomidine** that you place under your tongue or behind your lower lip.[2][4] The medication is self-administered under the supervision of a healthcare provider, who will monitor your vital signs and alertness after administration to prevent falls and fainting.[3] IGALMI is mint-flavored and designed with a mucoadhesive film so it cannot be spit out.[6] The safety and effectiveness of IGALMI have not been established beyond 24 hours from the first dose, and it is not approved for use in children.[2][4] ## Who Qualifies for Assistance? While specific income thresholds for BioXcel Therapeutics' patient assistance program are not detailed in available resources, patient assistance programs typically serve uninsured and underinsured patients who meet income eligibility requirements. To determine if you qualify, you should contact the program directly. **Important eligibility considerations:** - You must have a valid prescription for IGALMI from your healthcare provider - The program is designed to help patients who cannot afford their medication - Your healthcare provider or their office staff can help determine your eligibility ## Insurance Requirements IGALMI may be covered differently depending on your insurance type and where you receive treatment. If you receive IGALMI in a hospital setting, the cost may be billed through your medical coverage rather than prescription drug coverage, as a healthcare professional administers or supervises the dose.[7] If you have insurance, the patient assistance program may help cover your copayments or coinsurance. If you are uninsured, the program may provide medication at reduced cost or free of charge, depending on your financial situation. ## How to Apply **Step 1: Get a Prescription** Work with your healthcare provider to obtain a prescription for IGALMI for the acute treatment of agitation. **Step 2: Contact the Program** Call the patient assistance program at **1-833-201-1088** to speak with a representative who can: - Answer questions about your eligibility - Guide you through the application process - Help you gather necessary documentation **Step 3: Complete Your Application** Provide the information requested by the program representative. Be prepared to discuss: - Your current income and household size - Your insurance status (if applicable) - Your prescription and medical history - Any financial hardship you are experiencing **Step 4: Submit Documentation** Your healthcare provider's office may need to submit your prescription and medical information to support your application. **Step 5: Receive Approval and Medication** Once approved, you will receive information about how to obtain your IGALMI. ## Important Safety Information Before Starting IGALMI Before taking IGALMI, inform your healthcare provider about:[2] - Any heart problems, low potassium, low magnesium, or low blood pressure - Low heart rate, diabetes, high blood pressure, or history of fainting - Liver impairment or kidney problems - Pregnancy or breastfeeding status - All medications you take, including prescription drugs, over-the-counter medicines, vitamins, and herbal supplements - Any drugs that lower blood pressure, change heart rate, or include anesthetics, sedatives, hypnotics, and opioids **Serious side effects may include:**[2] - Decreased blood pressure or low blood pressure upon standing - Slower than normal heart rate - These effects may be more likely in patients with low blood volume, diabetes, chronic high blood pressure, and older patients Your healthcare provider will monitor your vital signs and alertness after you take IGALMI to prevent falls or fainting.[3] ## Timeline and Delivery The specific processing time for applications and delivery methods are not detailed in current program information. When you call **1-833-201-1088**, ask about: - How long approval typically takes - How your medication will be delivered (mail, pharmacy pickup, or direct to your healthcare provider) - Whether expedited processing is available for urgent situations ## What If Your Application Is Denied? If your application for patient assistance is denied, ask the program representative: - The specific reason for denial - Whether you can reapply with additional information - About alternative options, such as: - Discussing generic alternatives with your healthcare provider - Exploring other patient assistance programs - Checking if you qualify for government programs like Medicaid - Using prescription discount programs or coupons (some sources indicate savings up to 80% may be available through certain pharmacy discount programs)[7] ## Refills and Reauthorization When you call the program at **1-833-201-1088**, ask about: - How to request refills of your medication - Whether your assistance needs to be reauthorized periodically - How to update your information if your income or insurance status changes - The process for continuing assistance beyond your initial prescription ## Important Limitations IGALMI is indicated only for the acute treatment of agitation—meaning short-term use during agitation episodes. The safety and effectiveness have not been established beyond 24 hours from the first dose.[1][3][4] This is not a maintenance medication for ongoing treatment of schizophrenia or bipolar disorder. ## Disclaimer This guide provides general information about patient assistance programs for IGALMI. Program details, eligibility requirements, and benefits may change. For the most current and accurate information about BioXcel Therapeutics' patient assistance program, contact the program directly at **1-833-201-1088**. Always consult with your healthcare provider about whether IGALMI is appropriate for your medical condition and to discuss any questions about the medication or assistance program.
Program information last verified: March 30, 2026
Ready to apply for IGALMI assistance?
ProvisionRX manages the complete application process. Start your application in about 15 minutes.